The retail partnership will allow Walgreens to make Quidel’s non-prescription QuickVue at-home over-the-counter (OTC) Covid-19 tests available at 7,600 Walgreens stores in the US and Puerto Rico.
Moreover, consumers will also have the option to order the shelf-stable packages online at Walgreens.com for store pick-up or same-day delivery.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Each package contains two of the self-administered rapid antigen tests.
Quidel president and CEO Douglas Bryant said: “This retail collaboration with Walgreens will expedite in-store availability and over-the-counter sales of our QuickVue at-home OTC Covid-19 antigen tests to consumers nationwide.”
Although the QuickVue at-home OTC Covid-19 test has not been approved by the US Food and Drug Administration (FDA), it can be used under the FDA’s emergency use authorisation.
In a press statement, Quidel said: “The QuickVue at-home Covid-19 test shows excellent performance, with positive results agreeing with PCR 83.5% of the time, and negative results agreeing 99.2% of the time, delivering confidence to individuals running the test and helping to prevent asymptomatic virus spread.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataLast month, Quidel signed a distribution and fulfilment agreement with McKesson to improve access to the QuickVue at-home OTC COVID-19 test for consumers.
McKesson will serve as the lead commercial partner for Quidel’s at-home OTC COVID-19 rapid antigen test orders.
Using the QuickVue OTC Covid-19 test, consumers can get highly accurate results in ten minutes or less from nasal swab samples, Quidel said.
